دورية أكاديمية
أعرض في EDS

Association of insulin treatment with gastric residue during an esophagogastroduodenoscopy

التفاصيل البيبلوغرافية
العنوان: Association of insulin treatment with gastric residue during an esophagogastroduodenoscopy
المؤلفون: Toshiko Kobori, Yukiko Onishi, Masahiko Iwamoto, Tetsuya Kubota, Takako Kikuchi, Tazu Tahara, Toshiko Takao, Hiroaki Fujiwara, Yoko Yoshida, Masato Kasuga
المصدر: Journal of Diabetes Investigation, Vol 13, Iss 3, Pp 501-504 (2022)
بيانات النشر: Wiley, 2022.
سنة النشر: 2022
المجموعة: LCC:Diseases of the endocrine glands. Clinical endocrinology
مصطلحات موضوعية: Gastric residue, Gastroparesis, Insulin treatment, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
الوصف: Abstract The purpose of this study was to investigate the association of glycemic control and diabetes treatment to gastric residue observed during an esophagogastroduodenoscopy. Among 6,592 individuals who had esophagogastroduodenoscopy at our clinic between 2003 and 2019, we retrospectively and longitudinally identified those who had gastric residue during an esophagogastroduodenoscopy. Other data collected were age, sex, diagnosis of diabetes, glycated hemoglobin and diabetes medication. Cox proportional hazards models were used to assess the association of these data with the occurrence of gastric residue. To the best of our knowledge, this is the first retrospective cohort study finding that undergoing insulin treatment is a risk factor for gastric residue independent of age, sex and diabetes or glycated hemoglobin.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2040-1124
2040-1116
العلاقة: https://doaj.org/toc/2040-1116Test; https://doaj.org/toc/2040-1124Test
DOI: 10.1111/jdi.13665
الوصول الحر: https://doaj.org/article/5e1f10b0db62487bbe4d38e972778db4Test
رقم الانضمام: edsdoj.5e1f10b0db62487bbe4d38e972778db4
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20401124
20401116
DOI:10.1111/jdi.13665